Skip to content
Open access · OA via OpenAlex

Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study

Jessica E. Harbison, Alexandra J. Roth‐Schulze, Lynne C. Giles, Cuong Duy Tran, Katrina Ngui, Megan A. S. Penno, Rebecca Louise Thomson, John M. Wentworth, Peter Grahame Colman, Maria E. Craig, Grant Morahan, Anthony T. Papenfuss, Simon Charles Barry, Leonard C. Harrison, Jennifer Couper

Pediatric Diabetes · 2019 · ▲ 136 citations

Abstract

AIMS/HYPOTHESIS: To investigate the longitudinal relationship between the gut microbiome, circulating short chain fatty acids (SCFAs) and intestinal permeability in children with islet autoimmunity or type 1 diabetes and controls. METHODS: We analyzed the gut bacterial microbiome, plasma SCFAs, small intestinal permeability and dietary intake in 47 children with islet autoimmunity or recent-onset type 1 diabetes and in 41 unrelated or sibling controls over a median (range) of 13 (2-34) months follow-up. RESULTS: Children with multiple islet autoantibodies (≥2 IA) or type 1 diabetes had gut microbiome dysbiosis. Anti-inflammatory Prevotella and Butyricimonas genera were less abundant and these changes were not explained by differences in diet. Small intestinal permeability measured by blood lactulose:rhamnose ratio was higher in type 1 diabetes. Children with ≥2 IA who progressed to type 1 diabetes (progressors), compared to those who did not progress, had higher intestinal permeability (mean [SE] difference +5.14 [2.0], 95% confidence interval [CI] 1.21, 9.07, P = .006), lower within-sample (alpha) microbial diversity (31.3 [11.2], 95% CI 9.3, 53.3, P = .005), and lower abundance of SCFA-producing bacteria. Alpha diversity (observed richness) correlated with plasma acetate levels in all groups combined (regression coefficient [SE] 0.57 [0.21], 95% CI 0.15, 0.99 P = .008). CONCLUSIONS/INTERPRETATION: Children with ≥2 IA who progress to diabetes, like those with recent-onset diabetes, have gut microbiome dysbiosis associated with increased intestinal permeability. Interventions that expand gut microbial diversity, in particular SCFA-producing bacteria, may have a role to decrease progression to diabetes in children at-risk.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1111/pedi.12865
Canonical
link ↗
Fetched
2026-10-29 MST

Cite this

APA
Harbison, J.E., Roth‐Schulze, A.J., Giles, L.C., Tran, C.D., Ngui, K., Penno, M.A.S., Thomson, R.L., Wentworth, J.M., Colman, P.G., Craig, M.E., Morahan, G., Papenfuss, A.T., Barry, S.C., Harrison, L.C., &amp; Couper, J. (2019). Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study. <em>Pediatric Diabetes</em>. https://doi.org/10.1111/pedi.12865
Vancouver
Harbison JE, Roth‐Schulze AJ, Giles LC, Tran CD, Ngui K, Penno MAS, et al. Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study. Pediatric Diabetes. 2019. doi:10.1111/pedi.12865.
BibTeX
@article{jessica2019Gutmic, title = {Gut microbiome dysbiosis and increased intestinal permeability in children with islet autoimmunity and type 1 diabetes: A prospective cohort study}, author = {Jessica E. Harbison and Alexandra J. Roth‐Schulze and Lynne C. Giles and Cuong Duy Tran and Katrina Ngui and Megan A. S. Penno and Rebecca Louise Thomson and John M. Wentworth and Peter Grahame Colman and Maria E. Craig and Grant Morahan and Anthony T. Papenfuss and Simon Charles Barry and Leonard C. Harrison and Jennifer Couper}, journal = {Pediatric Diabetes}, year = {2019}, doi = {10.1111/pedi.12865}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings